Previous research has emphasized the therapeutic benefit of promoting keratinocyte apoptosis in psoriasis, with compounds like erianin and sunitinib demonstrating efficacy via ROS-mediated and PI3K/Akt-dependent mechanisms [14,47]. This evidence concerns the gene AKT1 and psoriasis.